Novel therapeutic strategies for large vessel vasculitis

Rheumatic Disease Clinics of North America

Volumn 32, Issue 1, 2006, Pages 173-186

  Koening, Curry L ^a   Langford, Carol A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMINOTRANSFERASE; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; DEXAMETHASONE; ETANERCEPT; FOLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PREDNISONE; TUMOR NECROSIS FACTOR ANTIBODY;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ABSENCE OF SIDE EFFECTS; AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; AORTA ARCH SYNDROME; BLINDNESS; BYPASS SURGERY; CLINICAL TRIAL; CYSTITIS; DERMATITIS; DRUG FEVER; ENDARTERECTOMY; GASTROINTESTINAL HEMORRHAGE; GIANT CELL ARTERITIS; HEART MUSCLE REVASCULARIZATION; HEMOLYSIS; HERPES ZOSTER; HISTOPLASMOSIS; HUMAN; LIVER TOXICITY; MALAISE; METHEMOGLOBINEMIA; MOUTH ULCER; NAUSEA; OLIGOMENORRHEA; PATCH ANGIOPLASTY; PATHOGENESIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PNEUMONIA; PRIORITY JOURNAL; REVIEW; STENT; THROMBOCYTOPENIA; UNSPECIFIED SIDE EFFECT; VASCULAR PATENCY;

ANTI-INFLAMMATORY AGENTS; BIOLOGICAL RESPONSE MODIFIERS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNOSUPPRESSIVE AGENTS; PLATELET AGGREGATION INHIBITORS; TAKAYASU'S ARTERITIS; TEMPORAL ARTERITIS; VASCULAR SURGICAL PROCEDURES;

EID: 33344479034     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2005.09.006     Document Type: Review

References (91)

1. C. Salvarani, C.S. Crowson, and W.M. O'Fallon Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period Arthritis Rheum 51 2 2004 264 268
2. G. Nesher, Y. Berkun, and M. Mates Risk factors for cranial ischemic complications in giant cell arteritis Medicine (Baltimore) 83 2 2004 114 122
3. C.M. Weyand, and J.J. Goronzy Giant-cell arteritis and polymyalgia rheumatica Ann Intern Med 139 6 2003 505 515
4. C. Salvarani, L. Cimino, and P. Macchioni Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis Arthritis Rheum 53 2 2005 293 297
5. S.S. Hayreh, P.A. Podhajsky, and B. Zimmerman Occult giant cell arteritis: ocular manifestations Am J Ophthalmol 125 4 1998 521 526
6. D.M. Nuenninghoff, G.G. Hunder, and T.J. Christianson Mortality of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years Arthritis Rheum 48 12 2003 3532 3537
7. J.M. Evans, C.A. Bowles, and J. Bjornsson Thoracic aortic aneurysm and rupture in giant cell arteritis. A descriptive study of 41 cases Arthritis Rheum 37 10 1994 1539 1547
8. C.M. Weyand, and J.J. Goronzy Medium- and large-vessel vasculitis N Engl J Med 349 2 2003 160 169
9. V. Martinez-Taboada, N.N. Hunder, and G.G. Hunder Recognition of tissue residing antigen by T cells in vasculitic lesions of giant cell arteritis J Mol Med 74 11 1996 695 703
10. W.S. Wilke, and G.S. Hoffman Treatment of corticosteroid-resistant giant cell arteritis Rheum Dis Clin North Am 21 1 1995 59 71
11. C.M. Weyand, N.N. Hunder, and K.C. Hicok HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis Arthritis Rheum 37 4 1994 514 520
12. S.S. Hayreh, B. Zimmerman, and R.H. Kardon Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature Acta Ophthalmol Scand 80 4 2002 355 367
13. P.D. Aiello, J.C. Trautmann, and T.J. McPhee Visual prognosis in giant cell arteritis Ophthalmology 100 4 1993 550 555
14. V. Kyle, and B.L. Hazleman Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months Ann Rheum Dis 48 8 1989 658 661
15. G. Delecoeuillerie, P. Joly, and A. Cohen de Lara Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients) Ann Rheum Dis 47 9 1988 733 739
16. I. Lundberg, and E. Hedfors Restricted dose and duration of corticosteroid treatment in patients with polymyalgia rheumatica and temporal arteritis J Rheumatol 17 10 1990 1340 1345
17. G.G. Hunder, S.G. Sheps, and G.L. Allen Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis: comparison in a prospective study Ann Intern Med 82 5 1975 613 618
18. G.T. Liu, J.S. Glaser, and N.J. Schatz Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision Ophthalmology 101 11 1994 1779 1785
19. C.C. Chan, and J. O'Day Oral and intravenous steroids in giant cell arteritis Clin Experiment Ophthalmol 31 3 2003 179 182
20. G.W. Su, and R. Foroozan Update on giant cell arteritis Curr Opin Ophthalmol 14 6 2003 332 338
21. M.T. Bhatti, and H. Tabandeh Giant cell arteritis: diagnosis and management Curr Opin Ophthalmol 12 6 2001 393 399
22. R. Andersson, B.E. Malmvall, and B.A. Bengtsson Long-term corticosteroid treatment in giant cell arteritis Acta Med Scand 220 5 1986 465 469
23. M.E. Ellis, and S. Ralston The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome Ann Rheum Dis 42 2 1983 168 170
24. C.M. Weyand, J.W. Fulbright, and G.G. Hunder Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity Arthritis Rheum 43 5 2000 1041 1048
25. G. Nesher, M. Sonnenblick, and Y. Friedlander Analysis of steroid related complications and mortality in temporal arteritis: a 15-year survey of 43 patients J Rheumatol 21 7 1994 1283 1286
26. G.S. Hoffman, R.Y. Leavitt, and G.S. Kerr The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate Arthritis Rheum 35 11 1992 1322 1329
27. G.S. Hoffman, R.Y. Leavitt, and G.S. Kerr Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate Arthritis Rheum 37 4 1994 578 582
28. C.A. Langford, C. Talar-Williams, and K.S. Barron A staged approach to the treatment of Wegener's granulomatosis: induction of remission with glucocorticoids and daily cyclophosphamide switching to methotrexate for remission maintenance Arthritis Rheum 42 12 1999 2666 2673
29. G. Nesher, and M. Sonnenblick Steroid-sparing medications in temporal arteritis-report of three cases and review of 174 reported patients Clin Rheumatol 13 2 1994 289 292
30. P.L. Krall, D.J. Mazanec, and W.S. Wilke Methotrexate for corticosteroid-resistant polymyalgia rheumatica and giant cell arteritis Cleve Clin J Med 56 3 1989 253 257
31. C. Hernandez-Garcia, C. Soriano, and C. Morado Methotrexate treatment in the management of giant cell arteritis Scand J Rheumatol 23 6 1994 295 298
32. R.F. Spiera, H.J. Mitnick, and M. Kupersmith A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA) Clin Exp Rheumatol 19 5 2001 495 501
33. J.A. Jover, C. Hernandez-Garcia, and I.C. Morado Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial Ann Intern Med 134 2 2001 106 114
34. G.S. Hoffman, M.C. Cid, and D.B. Hellmann A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis Arthritis Rheum 46 5 2002 1309 1318
35. H.L. Feinberg, J.D. Sherman, and C.G. Schrepferman The use of methotrexate in polymyalgia rheumatica J Rheumatol 23 9 1996 1550 1552
36. M.J. van der Veen, H.J. Dinant, and C. van Booma-Frankfort Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis? Ann Rheum Dis 55 4 1996 218 223
37. G. Ferraccioli, F. Salaffi, and S. De Vita Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study J Rheumatol 23 4 1996 624 628
38. R. Caporali, M.A. Cimmino, and G. Ferraccioli Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial Ann Intern Med 141 7 2004 493 500
39. J.H. Stone Methotrexate in polymyalgia rheumatica: kernel of truth or curse of Tantalus? Ann Intern Med 141 7 2004 568 569
40. G. Nesher, Y. Berkun, and M. Mates Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis Arthritis Rheum 50 4 2004 1332 1337
41. Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group N Engl J Med 321 3 1989 129 135
42. P.M. Ridker, N.R. Cook, and I.M. Lee A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women N Engl J Med 352 13 2005 1293 1304
43. J.F. Mustard, R.L. Kinlough-Rathbone, and M.A. Packham Aspirin in the treatment of cardiovascular disease: a review Am J Med 74 6A 1983 43 49
44. C.M. Weyand, M. Kaiser, and H. Yang Therapeutic effects of acetylsalicylic acid in giant cell arteritis Arthritis Rheum 46 2 2002 457 466
45. D.B. Hellmann Low-dose aspirin in the treatment of giant cell arteritis Arthritis Rheum 50 4 2004 1026 1027
46. S.M. Weisman, and D.Y. Graham Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events Arch Intern Med 162 19 2002 2197 2202
47. D. Caspi, E. Lubart, and E. Graff The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients Arthritis Rheum 43 1 2000 103 108
48. B.F. Asztalos, K.V. Horvath, and J.R. McNamara Comparing the effects of five different statins on the HDL subpopulation profiles of coronary heart disease patients Atherosclerosis 164 2 2002 361 369
49. A. Garcia-Martinez, J. Hernandez-Rodriguez, and J.M. Grau Treatment with statins does not exhibit a clinically relevant corticosteroid-sparing effect in patients with giant cell arteritis Arthritis Rheum 51 4 2004 674 678
50. P.M. Ridker, N. Rifai, and M.A. Pfeffer Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators Circulation 98 9 1998 839 844
51. C. Abud-Mendoza, H. de la Fuente, and E. Cuevas-Orta Therapy with statins in patients with refractory rheumatic diseases: a preliminary study Lupus 12 8 2003 607 611
52. C.M. Weyand, W. Ma-Krupa, and J.J. Goronzy Immunopathways in giant cell arteritis and polymyalgia rheumatica Autoimmun Rev 3 1 2004 46 53
53. M. Field, A. Cook, and G. Gallagher Immuno-localisation of tumour necrosis factor and its receptors in temporal arteritis Rheumatol Int 17 3 1997 113 118
54. F. Cantini, L. Niccoli, and C. Salvarani Treatment of longstanding active giant cell arteritis with infliximab: report of four cases Arthritis Rheum 44 12 2001 2933 2935
55. A.L. Tan, J. Holdsworth, and C. Pease Successful treatment of resistant giant cell arteritis with etanercept Ann Rheum Dis 62 4 2003 373 374
56. P. Airo, C.M. Antonioli, and M. Vianelli Anti-tumour necrosis factor treatment with infliximab in a case of giant cell arteritis resistant to steroid and immunosuppressive drugs Rheumatology (Oxford) 41 3 2002 347 349
57. A.P. Andonopoulos, N. Meimaris, and D. Daoussis Experience with infliximab (anti-TNF alpha monoclonal antibody) as monotherapy for giant cell arteritis Ann Rheum Dis 62 11 2003 1116
58. E. Reinitz, and A. Aversa Long-term treatment of temporal arteritis with dapsone Am J Med 85 3 1988 456 457
59. P. Doury, S. Pattin, and F. Eulry The use of dapsone in the treatment of giant cell arteritis and polymyalgia rheumatica Arthritis Rheum 26 5 1983 689 690
60. M. De Silva, and B.L. Hazleman Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study Ann Rheum Dis 45 2 1986 136 138
61. C. Schaufelberger, R. Andersson, and E. Nordborg No additive effect of cyclosporin A compared with glucocorticoid treatment alone in giant cell arteritis: results of an open, controlled, randomized study Br J Rheumatol 37 4 1998 464 465
62. D. Wendling, B. Hory, and D. Blanc Cyclosporine: a new adjuvant therapy for giant cell arteritis? Arthritis Rheum 28 9 1985 1078 1079
63. S. Hall, and R. Buchbinder Takayasu's arteritis Rheum Dis Clin North Am 16 2 1990 411 422
64. G.S. Kerr, C.W. Hallahan, and J. Giordano Takayasu arteritis Ann Intern Med 120 11 1994 919 929
65. G.S. Hoffman Takayasu arteritis: lessons from the American National Institutes of Health experience Int J Cardiol 54 Suppl 1996 S99 S102
66. M. Vanoli, E. Daina, and C. Salvarani Takayasu's arteritis: A study of 104 Italian patients Arthritis Rheum 53 1 2005 100 107
67. G.S. Hoffman Treatment of resistant Takayasu's arteritis Rheum Dis Clin North Am 21 1 1995 73 80
68. E. Morales, C. Pineda, and M. Martinez-Lavin Takayasu's arteritis in children J Rheumatol 18 7 1991 1081 1084
69. C.M. Weyand, and J.J. Goronzy Molecular approaches toward pathologic mechanisms in giant cell arteritis and Takayasu's arteritis Curr Opin Rheumatol 7 1 1995 30 36
70. L. Del Corso, D. Moruzzo, and M. Agelli Takayasu's arteritis on steroid therapy. Seven years follow-up Panminerva Med 41 4 1999 355 358
71. F. Verlato, G. Salmistraro, and G.P. Avruscio Takayasu's arteritis: anatomic change before and after steroid therapy evaluated by angiography and echo-Doppler color-flow Int Angiol 11 3 1992 233 236
72. K. Tanigawa, K. Eguchi, and Y. Kitamura Magnetic resonance imaging detection of aortic and pulmonary artery wall thickening in the acute stage of Takayasu arteritis. Improvement of clinical and radiologic findings after steroid therapy Arthritis Rheum 35 4 1992 476 480
73. J.D. Gardner, K.R. Lee, and N.I. Abdou Takayasu's arteritis: reversal of pulse deficit after early treatment with corticosteroids J Rheumatol 11 1 1984 92 93
74. I. Ito Medical treatment of Takayasu arteritis Heart Vessels Suppl 7 1992 133 137
75. C.A. Langford, M.C. Sneller, and G.S. Hoffman Methotrexate use in systemic vasculitis Rheum Dis Clin North Am 23 4 1997 841 853
76. J.H. Shelhamer, D.J. Volkman, and J.E. Parrillo Takayasu's arteritis and its therapy Ann Intern Med 103 1 1985 121 126
77. F.J. Rodriguez-Hurtado, J.M. Sabio, and J. Lucena Ocular involvement in Takayasu's arteritis: response to cyclophosphamide therapy Eur J Med Res 7 3 2002 128 130
78. C. Talar-Williams, Y.M. Hijazi, and M.M. Walther Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis Ann Intern Med 124 5 1996 477 484
79. G.S. Hoffman, G.S. Kerr, and R.Y. Leavitt Wegener granulomatosis: an analysis of 158 patients Ann Intern Med 116 6 1992 488 498
80. A.K. Valsakumar, U.C. Valappil, and V. Jorapur Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu's arteritis J Rheumatol 30 8 2003 1793 1798
81. H. Horigome, T. Kamoda, and A. Matsui Treatment of glucocorticoid- dependent Takayasu's arteritis with cyclosporin Med J Aust 170 11 1999 566
82. E. Daina, A. Schieppati, and G. Remuzzi Mycophenolate mofetil for the treatment of Takayasu arteritis: report of three cases Ann Intern Med 130 5 1999 422 426
83. G.S. Hoffman, P.A. Merkel, and R.D. Brasington Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis Arthritis Rheum 50 7 2004 2296 2304
84. P. Liang, M. Tan-Ong, and G.S. Hoffman Takayasu's arteritis: vascular interventions and outcomes J Rheumatol 31 1 2004 102 106
85. F.A. Weaver, A.E. Yellin, and D.H. Campen Surgical procedures in the management of Takayasu's arteritis J Vasc Surg 12 4 1990 429 437 [discussion 38-9]
86. R. Pajari, P. Hekali, and P.T. Harjola Treatment of Takayasu's arteritis: an analysis of 29 operated patients Thorac Cardiovasc Surg 34 3 1986 176 181
87. M. Yamato, J.W. Lecky, and K. Hiramatsu Takayasu arteritis: radiographic and angiographic findings in 59 patients Radiology 161 2 1986 329 334
88. P. Lagneau, J.B. Michel, and P.N. Vuong Surgical treatment of Takayasu's disease Ann Surg 205 2 1987 157 166
89. T. Miyata, O. Sato, and J. Deguchi Anastomotic aneurysms after surgical treatment of Takayasu's arteritis: a 40-year experience J Vasc Surg 27 3 1998 438 445
90. P. Liang, and G.S. Hoffman Advances in the medical and surgical treatment of Takayasu arteritis Curr Opin Rheumatol 17 1 2005 16 24
91. S. Sharma, H. Gupta, and A. Saxena Results of renal angioplasty in nonspecific aortoarteritis (Takayasu disease) J Vasc Interv Radiol 9 3 1998 429 435